Company / AR per Share
NovaBay Pharmaceuticals, Inc. AR per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.07
FY2023
5-year range
$0.07 / $0.97
FY2022-FY2023
Trend
-93.0%
vs FY2022
Sector context
#95 of 115
Health Care
What the data says
NovaBay Pharmaceuticals, Inc.'s ar per share of $0.07 is lower than 83% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
0.07 in FY2023.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 115This company $0.07 Sector average $27.09
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2023, ar per share decreased 93.0% year-over-year.
- Ranks #95 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.07 | -93.0% |
| FY2022 | $0.97 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026